van Haelst Paul L, Brügemann Johan, Diercks Gilles F, Suurmeijer Albert, van Veldhuisen Dirk J
Department of Cardiology, University Medical Center Groningen, NL-9700RB Groningen, The Netherlands.
Cardiovasc Pathol. 2006 Jul-Aug;15(4):228-30. doi: 10.1016/j.carpath.2006.03.005.
Giant cell myocarditis (GCM) is a serious condition that warrants immediate diagnosis and treatment. It often presents as rapidly progressive heart failure and/or malignant ventricular arrhythmias. Here, we describe a 34-year-old patient with myasthenia gravis who presented with GCM 2 weeks after resection of a thymoma. A cardiac biopsy confirming the diagnosis was done within 3 days after admission. After institution of an aggressive immunosuppressive drug regimen, implantation of an implantable cardioverter defibrillator, and intensive cardiac rehabilitation, the patient recovered dramatically. In control biopsies after 4 weeks and 6 months, no more giant cells were found. We conclude that, in the case of nonischemic acute heart failure in young patients, a biopsy should be performed as soon as possible to prevent an unfavourable outcome of this often fatal disease.
巨细胞性心肌炎(GCM)是一种严重疾病,需要立即诊断和治疗。它常表现为快速进展的心力衰竭和/或恶性室性心律失常。在此,我们描述一名34岁重症肌无力患者,其在胸腺切除术后2周出现GCM。入院后3天内进行了心脏活检以确诊。在采取积极的免疫抑制药物治疗方案、植入植入式心脏复律除颤器以及强化心脏康复治疗后,患者显著康复。在4周和6个月后的对照活检中,未再发现巨细胞。我们得出结论,对于年轻患者的非缺血性急性心力衰竭,应尽快进行活检,以防止这种常为致命性疾病出现不良后果。